2020
DOI: 10.5348/101125z01dm2020cr
|View full text |Cite
|
Sign up to set email alerts
|

Pleural effusion revealing a malignant rhabdoid tumor of the chest wall in an infant: A case report and literature review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The main differential for the tumor in our case was an epithelioid sarcoma. Both tumors can have rhabdoid morphology, with a loss of INI-1 , while epithelial and mesenchymal markers are positive, whereas rhabdoid tumors express epithelial, mesenchymal, and neural markers [ 11 ], and both tumors show immunopositivity for keratins and EMA, with occasional staining for desmin and CEA. CD34 can be used as a differential tool since epithelioid sarcoma is CD34 positive in 50% of cases, while rhabdoid tumors are always negative [ 35 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The main differential for the tumor in our case was an epithelioid sarcoma. Both tumors can have rhabdoid morphology, with a loss of INI-1 , while epithelial and mesenchymal markers are positive, whereas rhabdoid tumors express epithelial, mesenchymal, and neural markers [ 11 ], and both tumors show immunopositivity for keratins and EMA, with occasional staining for desmin and CEA. CD34 can be used as a differential tool since epithelioid sarcoma is CD34 positive in 50% of cases, while rhabdoid tumors are always negative [ 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…Diagnosis is challenging, but immunohistochemical evaluation allowing detection of INI-1 loss has made the diagnosis of this entity easier. INI-1 loss reflects the presence of SMARCB1 mutations, a sensitive marker for malignant rhabdoid tumors [ 11 ].…”
Section: Introductionmentioning
confidence: 99%